Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €43.48B | €38.13B | €153.51B | €42.01B | €37.20B |
| Total Operating Revenue | €43.48B | €38.13B | €153.51B | €42.01B | €37.20B |
| Cost of Revenue | €38.71B | €33.70B | €155.63B | – | – |
| Gross Profit | €4.77B | €4.43B | -€2.12B | – | – |
| Operating Expense | €3.79B | €3.74B | €20.11B | – | – |
| Selling and Admin Expenses | €2.48B | €2.30B | €8.97B | – | – |
| Research & Development | €1.31B | €1.44B | €11.15B | – | – |
| Operating Profit | €983.00M | €687.00M | -€22.23B | – | – |
| Net Non-Operating Interest Income (Expense) | -€210.00M | -€183.00M | -€258.00M | – | – |
| Non-Operating Interest Income | €255.00M | €215.00M | €1.22B | – | – |
| Non-Operating Interest Expense | €465.00M | €398.00M | €1.48B | – | – |
| Other Income (Expense) | -€273.00M | €34.00M | -€4.12B | – | – |
| Gain on Sale of Security | €81.00M | €23.00M | -€1.91B | – | – |
| Earnings from Equity Interest | €32.00M | €111.00M | -€1.27B | – | – |
| Special Income (Charges) | -€386.00M | -€100.00M | -€940.00M | – | – |
| -Less:Restructuring and Mergern & Acquisition | €384.00M | €98.00M | €913.00M | – | – |
| -Less:Write Off | €2.00M | €2.00M | €27.00M | – | – |
| Pretax Profit | €500.00M | €538.00M | -€26.61B | – | – |
| Tax | €207.00M | €161.00M | -€4.27B | – | – |
| Net Profit | €293.00M | €377.00M | -€22.33B | – | – |
| Profit from Continuing Operations | €293.00M | €377.00M | -€22.33B | – | – |
| Minority Interests | €27.00M | -€13.00M | €36.00M | – | – |
| Net Income to Parent Company | €266.00M | €390.00M | -€22.37B | – | – |
| Net Income to Common Stockholders | €266.00M | €390.00M | -€22.37B | – | – |
| Basic EPS | €0.07 | €0.14 | -€7.75 | – | – |
| Diluted EPS | €0.07 | €0.14 | -€7.75 | – | – |
| Dividend Per Share | €0.00 | €0.00 | €0.68 | €0.00 | €0.00 |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q2 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €213.42B | €207.42B | €195.15B | €195.15B | €200.68B |
| Total Current Assets | €90.38B | €89.33B | €80.54B | €80.54B | €80.52B |
| Cash and Cash Equivalents & Short-Term Investments | €34.43B | €32.73B | €31.32B | €31.32B | €32.67B |
| -Cash and Cash Equivalents | €33.70B | €31.95B | €30.15B | €30.15B | €30.66B |
| -Short Term Investments | €734.00M | €778.00M | €1.18B | €1.18B | €2.01B |
| Receivables | €25.21B | €25.88B | €21.81B | €21.81B | €20.82B |
| -Accounts Receivable | €7.29B | €6.56B | €5.66B | €5.66B | €6.36B |
| -Taxes Receivable | €4.71B | €5.09B | €4.47B | €4.47B | €4.43B |
| -Other Receivables | €13.21B | €14.23B | €11.68B | €11.68B | €10.03B |
| Prepaid Assets | €1.35B | €1.37B | €1.24B | €1.24B | €1.64B |
| Inventory | €23.99B | €24.96B | €22.15B | €22.15B | €21.81B |
| Restricted Cash | €0.00 | €0.00 | €2.00M | €2.00M | €43.00M |
| Other Current Assets | €4.91B | €3.87B | €3.62B | €3.62B | €2.94B |
| Total Non-Current Assets | €123.04B | €118.08B | €114.62B | €114.62B | €120.16B |
| Net PPE | €46.13B | €44.91B | €42.96B | €42.96B | €44.89B |
| Investments and Advances | €8.97B | €8.82B | €8.65B | €8.65B | €10.31B |
| -Available for Sale Securities | €632.00M | €469.00M | €469.00M | €469.00M | €615.00M |
| -Long Term Equity Investment | €7.34B | €7.49B | €7.28B | €7.28B | €8.63B |
| Financial Assets | €175.00M | €245.00M | €316.00M | €316.00M | €273.00M |
| Non Current Accounts Receivables | €12.69B | €9.68B | €9.16B | €9.16B | €8.34B |
| Non-Current Prepaid Assets | €479.00M | €475.00M | €395.00M | €395.00M | €380.00M |
| Goodwill and Other Intangible Assets | €45.77B | €45.30B | €44.89B | €44.89B | €49.79B |
| -Goodwill | €14.47B | €14.35B | €14.01B | €14.01B | €14.08B |
| -Other Intangible Assets | €31.30B | €30.95B | €30.88B | €30.88B | €35.71B |
| Defined Pension Benefit | €984.00M | €1.01B | €967.00M | €967.00M | €1.00B |
| Non-Current Deferred Assets | €6.56B | €6.51B | €6.38B | €6.38B | €4.47B |
| Other Non-Current Assets | €1.28B | €1.14B | €902.00M | €902.00M | €704.00M |
| Total Liabilities | €151.69B | €146.47B | €141.15B | €141.15B | €127.16B |
| Total Current Liabilities | €87.19B | €86.34B | €78.74B | €78.74B | €75.91B |
| Payables | €45.01B | €43.70B | €39.38B | €39.38B | €39.66B |
| -Accounts Payable | €33.60B | €33.90B | €30.00B | €30.00B | €29.92B |
| -Total Tax Payable | €2.33B | €2.05B | €1.85B | €1.85B | €1.72B |
| -Other Payable | €9.08B | €7.75B | €7.53B | €7.53B | €8.02B |
| Current Accrued Expenses | €6.72B | €7.14B | €6.32B | €6.32B | €6.33B |
| Short-Term Debt and Capital Lease Obligation | €15.86B | €17.33B | €14.12B | €14.12B | €13.29B |
| -Current Debt | €14.97B | €16.43B | €13.30B | €13.30B | €12.52B |
| -Current Capital Lease Obligation | €889.00M | €895.00M | €818.00M | €818.00M | €773.00M |
| Current Provisions | €14.78B | €13.57B | €14.32B | €14.32B | €11.82B |
| Current Deferred Liabilities | €790.00M | €763.00M | €744.00M | €744.00M | €837.00M |
| Other Current Liabilities | €3.48B | €3.32B | €3.34B | €3.34B | €3.50B |
| Total Non-Current Liabilities | €64.50B | €60.14B | €62.41B | €62.41B | €51.25B |
| Long Term Accounts Payable and Other Payables | €3.18B | €3.20B | €3.01B | €3.01B | €3.23B |
| Non-Current Accrued Expenses | €784.00M | €822.00M | €789.00M | €789.00M | €824.00M |
| Long Term Debt and Capital Lease Obligation | €36.20B | €30.59B | €31.83B | €31.83B | €27.51B |
| -Long Term Debt | €34.50B | €28.93B | €30.19B | €30.19B | €25.95B |
| -Long Term Capital Lease Obligation | €1.70B | €1.66B | €1.64B | €1.64B | €1.56B |
| Derivative Product Liabilities | €28.00M | €16.00M | €27.00M | €27.00M | €78.00M |
| Non-Current Liabilities | €16.39B | €17.45B | €18.60B | €18.60B | €9.28B |
| Non-Current Deferred Liabilities | €2.69B | €2.70B | €2.74B | €2.74B | €4.92B |
| Employee Benefits | €4.66B | €4.74B | €4.80B | €4.80B | €5.16B |
| Other Non-Current Liabilities | €560.00M | €623.00M | €635.00M | €635.00M | €255.00M |
| Total Equity | €61.74B | €60.95B | €54.00B | €54.00B | €73.52B |
| Stockholders' Equity | €61.28B | €60.53B | €53.55B | €53.55B | €73.12B |
| Capital Stock | €37.00M | €37.00M | €37.00M | €37.00M | €37.00M |
| -Common Stock | €37.00M | €37.00M | €37.00M | €37.00M | €37.00M |
| Retained Earnings | €53.93B | €53.64B | €53.27B | €53.27B | €73.22B |
| Less: Treasury Stock | €285.00M | €285.00M | €285.00M | €285.00M | €285.00M |
| Gains/Losses Not Affecting Retained Earnings | €2.53B | €2.12B | €532.00M | €532.00M | €150.00M |
| Other Equity Interests | €5.07B | €5.01B | – | – | – |
| Minority Interests | €458.00M | €418.00M | €450.00M | €450.00M | €406.00M |
| -Gross PPE | – | – | €91.04B | €91.04B | – |
| -Accumulated Depreciation | – | – | -€48.08B | -€48.08B | – |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q2 (EUR) |
2025 Q1 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€169.00M | -€2.72B | -€4.65B | €559.00M | -€2.85B |
| Net cash flow from continuing operations | -€169.00M | -€2.72B | -€4.65B | €559.00M | -€2.85B |
| Net Income from Continuing Operations | €500.00M | €538.00M | -€26.61B | -€2.46B | -€413.00M |
| Gain/Loss from Continuing Operations | -€92.00M | -€102.00M | €3.03B | €601.00M | -€14.00M |
| Depreciation & Depletion & Amortization | €1.60B | €1.57B | €6.98B | €1.70B | €1.88B |
| Other Non-Cash Items | €165.00M | €629.00M | €10.80B | €1.73B | €426.00M |
| Change in Working Capital | -€4.99B | -€3.05B | €1.08B | -€2.75B | -€3.30B |
| -Change in Receivables | -€1.96B | -€1.09B | -€5.53B | -€913.00M | -€825.00M |
| -Change in Other Current Assets | -€803.00M | -€1.27B | -€5.38B | -€1.29B | -€1.54B |
| -Change In Other Working Capital | -€2.22B | -€693.00M | €11.04B | -€548.00M | -€938.00M |
| Net cash flow from investing | -€1.71B | -€1.32B | -€5.90B | -€1.14B | -€1.01B |
| Net Cash Flow from Continuing Investing Activities | -€1.71B | -€1.32B | -€5.90B | -€1.14B | -€1.01B |
| Net PPE Purchase and Sale | -€1.45B | -€1.61B | -€8.91B | -€2.48B | -€2.53B |
| Net Business Purchase and Sale | -€181.00M | -€57.00M | €60.00M | €127.00M | €15.00M |
| Net Investment Purchase and Sale | -€3.00M | €465.00M | €2.86B | €1.27B | €1.18B |
| Net Other Investing Changes | -€67.00M | -€109.00M | €100.00M | -€52.00M | €328.00M |
| Financing Cash Flow | €3.53B | €5.52B | €7.57B | -€721.00M | €2.66B |
| Net Cash Flow from Continuing Financing Activities | €3.53B | €5.52B | €7.57B | -€721.00M | €2.66B |
| Net Issuance Payments Of Debt | €3.55B | €631.00M | €9.49B | €1.24B | €2.66B |
| Net Other Financing Charges | -€42.00M | €4.89B | -€5.00M | – | – |
| Ending Cash Balance | €33.70B | €31.95B | €30.15B | €30.66B | €32.78B |
| Net Change in Cash | €1.65B | €1.49B | -€2.68B | -€1.18B | -€1.03B |
| Beginning Cash Balance | €31.95B | €30.15B | €34.10B | €32.78B | €34.10B |
| Effect of Exchange Rate Changes | €100.00M | €313.00M | -€1.28B | -€942.00M | -€294.00M |
| Free Cash Flow | -€1.63B | -€4.35B | -€13.79B | -€1.94B | -€5.50B |
| -Change in Inventory | – | – | -€2.54B | – | – |
| -Change in Payables and Accrued Expense | – | – | €3.48B | – | – |
| Net Common Stock Issuance | – | – | €49.00M | – | – |
| Cash Dividends Paid | – | – | -€1.96B | – | – |
No comments yet — be the first to weigh in on STLA.